Ces radiol. 2021, 75(1):94-101 | DOI: 10.55095/CesRadiol2021/012
Diagnostic Approach to Head and Neck Cancer - a review of imaging methods and their application in clinical practiceReview article
- 1 Klinika zobrazovacích metod FN u svaté Anny Brno a LF MU, Brno
- 2 Klinika otorhinolaryngologie a chirurgie hlavy a krku FN u svaté Anny a LF MU, Brno
Imaging methods are an integral part of staging, treatment planning and surveillance of patients with head and neck cancer. Ultrasound (US) is noninvasive, cost-effective and useful tool for evaluation of cervical lymph nodes (N staging) and other superficial structures, but it is operator-dependent. CT of the neck is useful for imaging of primary tumor (T staging) and cervical lymph nodes (N staging), but in T staging it is limited by the artifacts of metallic dental fillings in the oral cavity and in lower poles of parotid glands. MRI of the neck has superior soft tissue contrast than CT, imaging is much less susceptible for dental filling artifacts, therefore it is prior to CT in T staging especially by tumors of oropharynx and oral cavity. In N staging, both methods (MRI and CT) are almost equivalent. FDG-PET/CT displays an increased metabolic activity of malignant cervical tumors and their regional and distant metastases (M staging). Therefore it is the method of definitive staging, restaging and method for detection of occult primary tumor. Advanced hybrid FDG-PET/MRI examination offers an advantage of detailed characterization of primary tumor together with definitive staging with significantly decreased radiation dose for patient.
Keywords: head and neck cancer, imaging methods, diagnostics, staging
Accepted: January 31, 2021; Published: March 1, 2021 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Palasz P, Adamski L, Gaska-Chrzastek M, et al. Contemporary diagnostic imaging of oral squamous cell carcinoma - a review of literature. Polish Journal of Radiology 2017; 82: 193-202.
Go to original source...
Go to PubMed...
- Brierley JD, Gospodarowicz MK, Wittekind Ch. TNM klasifikace zhoubných novotvarů - osmé vydání, česká verze. Chichester: Wiley-Blackwell 2017; 31-65.
Go to original source...
- Seeburg DP, Baer AH, Aygun N. Imaging of Patients with Head and Neck Cancer. Oral Maxillofacial Surgery Clinics of North America 2018; 30: 421-433.
Go to original source...
Go to PubMed...
- Reema G, Moore W, Sumer B, et al. Clinical Practise in PET/CT for Management of Head and Neck Squamous Cell Cancer. American Journal of Roentgenology 2017; 209: 289-303.
Go to original source...
Go to PubMed...
- Ferda J, Ferdová E, Baxa J. Hybridní zobrazení PET/MR. Ces Radiol 2017; 71(4): 353-362.
Go to original source...
- Ferda J, Ferdová E, Baxa J, et al. Současný pohled na staging karcinomu orofaryngu. Ces Radiol 2019; 73(2): 79-86.
Go to original source...
- Peterson F. Nasopharyngeal carcinoma: a review. Seminars in Diagnostic Pathology 2015; 32(1): 54-73.
Go to original source...
Go to PubMed...
- Vokes EE, Liebowitz DN, Weichselbaum RR. Nasopharyngeal carcinoma. Lancet 1997; 350(9084): 1087-1091.
Go to original source...
Go to PubMed...
- Adam Z, Vorlíček J, Vaníček J, et al. Diagnostické a léčebné postupy u maligních chorob, 1. vydání. Praha: Grada Publishing 2002; 21-33.
- Trotta BM, Pease CS, Rasamny JJ, et al. Oral cavity and oropharyngeal squamous cell cancer: key imaging findings for staging and treatment planning. Radiographics 2011; 31(2): 339-354.
Go to original source...
Go to PubMed...
- Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papilloma virus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology 2011; 29(32): 4294-3014.
Go to original source...
Go to PubMed...
- Gillison ML, Trotti AM, Harris J, et al. Radiotherapy plus cetuximab or cisplatin HPV - positive oropharyngeal cancer. Lancet 2019; 393: 10166: 40-50.
Go to original source...
Go to PubMed...
- Becker M, Zbaeren P, Delavolle J, et al. Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at CT. Radiology 1997; 203(2): 521-532.
Go to original source...
Go to PubMed...
- Rahman M, Siddigue MA, Ali MI, et al. Study of commonest variety of sinonasal malignancy and its sex wise distributon. Mymensingh Medical Journal 2015; 24(4): 832-837.
- Christe A, Waldherr C, Hallett R, et al. MR imaging of parotid tumors: typical leasion characteristics in MR imaging improve discrimination between benign and malignant disease. American Journal of Neuroradiology 2011; 32(7): 1202-1207.
Go to original source...
Go to PubMed...
- Friendman ER, Saindane AM. Pitfalls in the staging of cancer of the major salivary glands neoplasms. Neuroimaging Clinics of North America 2013; 23(1): 107-122.
Go to original source...
Go to PubMed...
- Som P, Brandwein MS. Lymph nodes. In: Som PM, Curtin HD (eds.) Head and Neck imaging, 5th edition. St' Louis: Mosby 2011.
- Blatt S, Ziebart T, Krueger M, et al. Diagnosing oral squamous cell carcinoma: How much imaging do we really need? A review of current literature. Journal of cranio-maxillo-facial surgery 2016; 44(5): 538-549.
Go to original source...
Go to PubMed...
- Roh JL, Park JP, Kim JS, et al. 18F-fluordeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Radiology 2014; 271(1): 153-161.
Go to original source...
Go to PubMed...
- Deschler DG, Moore MG, Smith RV, et al. Quick Reference Guide to TNM staging of Head and Neck Cancer and Neck Dissection Classification, 4th edition. Alexandria, VA: American Academy of Otolaryngology - Head and Neck Surgery Foundation 2014; 25-28.
- Roman BR, Patel SG, Wang MB, et al. Guideline familiarity predicts variation in self-reported use of routine surveillance PET/CT by physicians who treat head and neck cancer. Journal of the National Comprehensive Cancer Network 2015; 13(1): 69-77.
Go to original source...
Go to PubMed...
- Gourin CG, Boyce BJ, Williams HT, et al. Revisiting the role of positron-emission tomography/computed tomography in determining the need of planned neck dissection following chemoradiation for advanced head and neck cancer. Laryngoscope 2009; 119(11): 2150-2155.
Go to original source...
Go to PubMed...
- Pryor DI, Porceddu SV, Scuffham PA, et al. Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma. Head and Neck 2013; 35(9): 1287-1294.
Go to original source...
Go to PubMed...
- Aiken AH, Farley A, Baugnon KL, et al. Implementation of a novel surveillance template for head and neck cancer: neck imaging reporting and data systém (NI-RADS). Journal of American College of Radiology 2016; 13(6): 743-746.
Go to original source...
Go to PubMed...
- Hueller MW. PET/MR in Head nad Neck Cancer - An Update. Seminars in nuclear medicine 2021; 51(1): 26-28.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.